Abstract |
Several studies have suggested that insulin-like growth factors (IGF) are related to cancer risk. We investigated the associations between serum levels of IGF-I and IGF-binding protein-3 and glioma risk. A nested case-control study was conducted within a cancer prevention study, including 29,133 men (ages 50-69 years). In total, 22 glioma cases and 400 randomly selected controls were included. Serum samples were collected a minimum of 5 years before cancer diagnosis. Serum concentrations were measured using ELISA and divided into tertiles based on measurements among controls. Odds ratios and 95% confidence intervals were calculated using the lowest tertile as the reference category. No statistical association was detected between glioma and IGF-binding protein-3. IGF-I was inversely associated with glioma when comparing the lowest tertile with the other tertiles combined (odds ratio, 0.3; 95% confidence interval, 0.1-0.7). The results encourage future research on IGFs in relation to brain tumors in larger studies.
|
Authors | Stefan Lönn, Peter D Inskip, Michael N Pollak, Stephanie J Weinstein, Jarmo Virtamo, Demetrius Albanes |
Journal | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
(Cancer Epidemiol Biomarkers Prev)
Vol. 16
Issue 4
Pg. 844-6
(Apr 2007)
ISSN: 1055-9965 [Print] United States |
PMID | 17416782
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
|
Chemical References |
- Biomarkers, Tumor
- Insulin-Like Growth Factor Binding Protein 3
- Insulin-Like Growth Factor I
|
Topics |
- Biomarkers, Tumor
(blood)
- Brain Neoplasms
(blood)
- Case-Control Studies
- Enzyme-Linked Immunosorbent Assay
- Female
- Glioma
(blood)
- Humans
- Insulin-Like Growth Factor Binding Protein 3
(blood)
- Insulin-Like Growth Factor I
(metabolism)
- Male
- Middle Aged
- Risk
|